Development, validation, and preliminary phenotypic characterization of a Col6a3 knockout mouse model targeting exon...

Area of Science:

• Genetics
• Molecular Biology
• Animal Models

Background:

• Mutations in the COL6A3 gene cause collagen VI-related myopathies due to altered COL6A3 protein expression or localization.
• Existing Col6a3 mouse models do not completely eliminate COL6A3 protein expression, limiting their utility.
• Understanding the functional consequences of COL6A3 loss is crucial for modeling these diseases.

Purpose of the Study:

• To develop and validate a novel CRISPR-based knockout mouse model targeting the Col6a3 gene.
• To characterize the preliminary phenotype of this new mouse model.
• To provide a tool for studying COL6A3 biology and collagen VI-associated diseases.

Main Methods:

• CRISPR-Cas9 gene editing was used to target exon 3 of the Col6a3 gene.
• A knockout mouse model, designated Col6a3^d3/d3, was generated and validated.
• Phenotypic characterization included mRNA expression analysis, mass spectrometry for protein detection, and histological examination of muscle tissue.

Main Results:

• The Col6a3^d3/d3 mouse model exhibits undetectable COL6A3 protein despite detectable mRNA levels.
• Histological analysis of quadriceps muscle revealed an increased frequency of internally nucleated muscle cells, indicative of a myopathy.
• Col6a3^d3/d3 mice displayed proportional reductions in size, fat, muscle, and bone mass compared to wild-type littermates.

Conclusions:

• A novel and validated Col6a3 knockout mouse model (Col6a3^d3/d3) has been successfully created.
• This model exhibits a myopathy phenotype and undetectable COL6A3 protein, making it suitable for disease modeling.
• The Col6a3^d3/d3 mouse serves as a valuable resource for further research into COL6A3 biology and collagen VI-related disorders.